Indee Labs (YC W17) has unique intracellular delivery technology that allows for the efficient development and scalable manufacturing of gene-modified cell therapies. We are currently able to deliver functional macromolecules (e.g., mRNA and Cas9 RNPs) to human primary T-cells (e.g., CD4+ and CD8+) with high efficiency (e.g., 40% to 70%), cell viability (e.g., greater than 70%) and recovery (e.g., greater than 80%).
We have a BSL-II lab space equipped for all things cell culture, including: (1) a Countess II FL Automated Cell Counter along with a (2) Attune NXT Flow Cytometer with the blue (488 nm), red (638 nm) and violet (405 nm) lasers. Plus, we have access to core facilities at [email protected] (qb3at953.com) in San Francisco's Dog Path.
We are available for co-development projects involving alternative cell types and macromolecules along with microfluidic device development.
Indee Labs (YC W17) has not received any reviews.
Indee Labs (YC W17) has not received any endorsements.